Photoprovocation Testing in Subjects With Cutaneous Lupus
NCT01516788 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19
Last updated 2021-07-13
Summary
Photosensitivity is well documented among lupus patients and is one of the diagnostic criteria for systemic lupus erythematosus (SLE). Photosensitivity is highly prevalent in lupus and has a wide range of clinical presentations. However, photosensitivity is a poorly defined in lupus and its pathogenesis is not well understood. The purpose of this study is to characterize the early clinical and histopathological changes in lupus skin that occur as a response to ultraviolet light.
Conditions
- Lupus Erythematosus
- Photosensitivity Conditions
Interventions
- OTHER
-
Phototesting
Single MED dose on Day 2
Sponsors & Collaborators
- lead OTHER
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-12-31
- Primary Completion
- 2018-07-02
- Completion
- 2018-07-02
Countries
- United States
Study Locations
More Related Trials
-
Comparison Between Early-onset and Late-onset Patients With Systemic Lupus Erythematosus.
NCT06294483 ·Status: ENROLLING_BY_INVITATION
-
TF, TFPI and Plasmin as Novel Bio-markers in Early Diagnosis of Lupus Nephritis
NCT04218890 ·Status: UNKNOWN
-
Translation of a Diagnostic Test for Lupus Flare Prediction From Bench to Clinic
NCT04018222 ·Status: UNKNOWN
-
An Investigation of NNC 0151-0000-0000 in Subjects With Systemic Lupus Erythematosus (SLE)
NCT01018238 ·Status: WITHDRAWN ·Phase: PHASE1
-
Anti KU Antibodies and Its Relationship With Systemic Lupus Erythematosus
NCT05900232 ·Status: UNKNOWN ·Phase: NA
-
Exploratory Study of Changes in Disease Activity and Biomarkers With ABR-215757 in Patients With Mild Active Systemic Lupus Erythematosus (SLE)
NCT00997100 ·Status: COMPLETED ·Phase: PHASE2
-
Cardiac and Laboratory Findings in Patients With Systemic Lupus Erythematosus
NCT03179046 ·Status: COMPLETED
-
Disease Activity Biomarkers in Patients With Systemic Lupus Erythematosus
NCT05443516 ·Status: RECRUITING
-
Biomarkers of Lupus Disease: Serial Biomarker Sampling in Patients With Active Systemic Lupus Erythematosus (SLE)
NCT00987831 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of Clinical Characteristics ,Risk Factors and Outcome of Lupus Nephritis Among Children With Systemic Lupus Erthromatousus in Sohag Univeristy Hospital
NCT06491602 ·Status: RECRUITING
-
Effect of Telitacicept on Transitional Regulatory B Cells in Patients With Systemic Lupus Erythematosus
NCT06137053 ·Status: RECRUITING
-
Fatigue, Depression, and Cortical Excitability in Systemic Lupus
NCT03165682 ·Status: UNKNOWN
-
Evaluation of Slit2 in Systemic Lupus Erythematosus and Systemic Sclerosis Patients
NCT05105217 ·Status: UNKNOWN
-
Omalizumab for Lupus
NCT01716312 ·Status: COMPLETED ·Phase: PHASE1
-
Disease Progression and Activity in Patients With Systemic Lupus Erythematosus
NCT00339261 ·Status: COMPLETED
-
Treatment of Cutaneous Lupus Erythematosus (CLE) With the 595 nm Flashlamp Pulsed Dye Laser
NCT00523588 ·Status: COMPLETED ·Phase: PHASE2
-
Subgrouping SLE - a New Approach to Understand the Pathogenesis and Improve Treatment
NCT07102030 ·Status: RECRUITING
-
IL17 in Systemic Lupus Erythematosus Patients: Association With Disease Activity and Organ Damage
NCT05045417 ·Status: UNKNOWN
-
Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus
NCT01510067 ·Status: RECRUITING
-
Serologically Active, Clinically Stable Systemic Lupus Erythematosus
NCT00000421 ·Status: COMPLETED ·Phase: PHASE2
-
Correlation Between Serum Uric Acid, Serum Homocysteine Level and Interleukin- 17 in Lupus Nephritis Patients
NCT07017868 ·Status: RECRUITING
-
SSerum/Urinary Monocyte Chemoattractant Protein-1 Level as a Marker for Lupus Nephritis
NCT03164720 ·Status: UNKNOWN
-
NFC Changes in SLE Patients and Its Correlation With Anti-U1RNPAntibodies and Disease Activity
NCT05106998 ·Status: UNKNOWN
-
The 2019 EULAR/ACR Classification Criteria as Predictor of Organ Damage in Systemic Lupus Erythematosus Patients
NCT06313151 ·Status: RECRUITING
-
Low-dose UVA1 Radiation in Cutaneous Lupus Patients
NCT01776190 ·Status: COMPLETED ·Phase: NA